Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 1:19 PM
Ignite Modification Date:
2025-12-25 @ 12:25 PM
NCT ID:
NCT02873195
Group ID:
EG001
Title:
Placebo, Bevacizumab, Capecitabine
Description:
Patients receive 1200 mg placebo IV over 30-60 minutes on day 1, 7.5 mg/kg bevacizumab IV over 30-90 minutes on day 1, and 850 or 1000 mg/m\^2 capecitabine PO BID on days 1-14. Courses repeat every 21 days in the absence of disease progression or unacceptable toxicity.
Deaths Number Affected:
23
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
46
Other Number Affected:
42
Other Number At Risk:
46
Study:
NCT02873195
Results Section:
NCT02873195
Adverse Events Module:
NCT02873195